How are topics selected?
Topics are chosen because they answer common patient questions, explain the reasoning behind clinical care or clarify fast-changing evidence and regulation. Search interest may identify a useful question, but it does not determine the clinical conclusion.
Which sources are prioritised?
Dr K Medical Wellness prioritises MHRA safety communications and UK product information, NICE guidance, NHS guidance, peer-reviewed randomised trials, systematic reviews, professional consensus statements and registered clinical-trial records.
Manufacturer announcements may be used only to describe clearly labelled preliminary pipeline status. They are not treated as peer-reviewed evidence and should not be the sole basis for a patient-facing clinical claim.
How is medical content reviewed?
Medical articles are written and medically reviewed by Dr Karen Egan, an experienced practising GP. Each article displays its publication date, last medical-review date, next evidence-review date and references.
How often is content checked?
Pages about medicines, adverse effects, licensing and investigational research are treated as high-volatility content and scheduled for review at least every three months. Lower-volatility clinical explainers are reviewed at a proportionate interval and sooner if material evidence changes.
What triggers an earlier review?
- MHRA safety guidance changes
- NICE guidance changes
- UK licensing, restriction or withdrawal changes
- A relevant phase 3 trial is published
- An investigational medicine receives or is refused authorisation
- Advertising rules change
- A material factual error is identified
How are corrections handled?
Material corrections should be made promptly, with the review date updated. A change in evidence, licensing or guidance should be described clearly rather than silently presenting an old claim as current.
How are educational and commercial content separated?
Commercial service pages promote medical assessment and care, not a prescription-only medicine. Named medicines may appear in clearly educational articles when clinically useful, but those articles present risks, limitations, uncertainty, licensing and sources together. Research-stage treatments are never presented as available care.
Do commercial relationships determine conclusions?
No. Clinical conclusions should follow the quality and relevance of the evidence. Commercial relationships must not determine which treatment is described as suitable or how research is interpreted.